![Holger N. Reithinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Holger N. Reithinger
Président chez
Allecra Therapeutics GmbH
Profil
Holger is a partner at Forbion, a leading European venture capital firm.
Forbion invests in young, innovative life science start-ups developing new drugs.
Holger has more than 20 years of experience as an investor in life science companies and is currently a supervisory, advisory or board member at Allecra GmbH, OMEICOS GmbH, and OMEICOS Ophthalmic Inc. Previously, Holger served on the boards of numerous life science companies, including Curetis N.V.
(IPO 2015), Cellnovo S.A. (IPO 2015), Epigenomics (IPO 2004), MBT (assets sold to Medigene), 4SC (IPO 2005), NeurogesX (IPO 2007), Fibrex Medical (assets licensed to Ikaria), Agendia, Santaris (sold to Roche 2014) and Rigontec (sold to MSD 2017) and catalYm.
Prior to his VC activities, Holger gained operational experience as a product development manager at Biometra/Whatman Plc, now part of GE Healthcare.
Postes actifs de Holger N. Reithinger
| Sociétés | Poste | Début |
|---|---|---|
Forbion Capital Partners Germany GmbH
 Forbion Capital Partners Germany GmbH Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | 17/03/2010 |
Allecra Therapeutics GmbH
 Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures pharmaceuticals to combat multi drug-resistant bacterial infections | Président | - |
High-Tech Gründerfonds Management GmbH
 High-Tech Gründerfonds Management GmbH Investment ManagersFinance HTGF invests in companies located in Germany. The firm focuses on chemistry, digital tech, industrial tech and life sciences sectors. It participates in pre-seed and seed stage capital requirements with an investment size of EUR 0.8 - 30 million. It makes co-investments, follow-on financing and also acts as a lead investor. | Private Equity Investor | 01/09/2017 |
Anciens postes connus de Holger N. Reithinger
| Sociétés | Poste | Fin |
|---|---|---|
OMEICOS Therapeutics GmbH
 OMEICOS Therapeutics GmbH BiotechnologyHealth Technology Develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation | Directeur/Membre du Conseil | 30/06/2022 |
CatalYm GmbH
 CatalYm GmbH Pharmaceuticals: MajorHealth Technology Specializes in catalyzing immunotherapy | Président | 01/03/2021 |
Gotham Therapeutics Corp.
 Gotham Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical medicines | Directeur/Membre du Conseil | 01/07/2020 |
| CURETIS N.V. | Directeur/Membre du Conseil | 30/04/2018 |
Cellnovo Ltd.
 Cellnovo Ltd. Medical SpecialtiesHealth Technology Manufactures diabetes management devices | Directeur/Membre du Conseil | 01/01/2015 |
Formation de Holger N. Reithinger
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
25
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
3i Group Plc
 3i Group Plc Investment Trusts/Mutual FundsMiscellaneous Operates as an investment company that specializes in private equity and infrastructure | Miscellaneous |
FIBREX Medical, Inc.
 FIBREX Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides bio-pharmaceutical research development services | Commercial Services |
4SC AG
 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Whatman Ltd. (United Kingdom)
 Whatman Ltd. (United Kingdom) Industrial MachineryProducer Manufacturing Develops, manufactures, and markets separation technology used for filtration, purification and storage of chemicals, and other liquids and samples | Producer Manufacturing |
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Epigenomics AG
 Epigenomics AG Medical SpecialtiesHealth Technology Engages in the development and commercialization of in vitro diagnostic tests for cancer | Health Technology |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Health Technology |
NeurogesX, Inc.
 NeurogesX, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pain management therapies | Health Technology |
The Global Life Science Ventures GmbH
 The Global Life Science Ventures GmbH Investment ManagersFinance GLSV is an active, long-term manager which aims to create and build value exclusively in life science companies in the UK, Switzerland, German-speaking countries and the US. They invest in many areas of the life sciences including the cancer, immunology, vaccines, biopharmaceuticals, indication-specific genomics, genomics tools, diagnostics, medical devices, healthcare services and cardiovascular areas. The firm primarily invests in early-stage companies that operate in significant markets with considerable upside potential, as well as in later-stage companies, including buyouts, which meet their investment in their home markets, GLSV is the lead investor or an active co-investor, while outside of their home markets they only act as a knowledgeable co-investor. | Finance |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johann Wolfgang Goethe-Universität Frankfurt am Main
 Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
High-Tech Gründerfonds Management GmbH
High-Tech Gründerfonds Management GmbH Investment ManagersFinance HTGF invests in companies located in Germany. The firm focuses on chemistry, digital tech, industrial tech and life sciences sectors. It participates in pre-seed and seed stage capital requirements with an investment size of EUR 0.8 - 30 million. It makes co-investments, follow-on financing and also acts as a lead investor. | Finance |
Cellnovo Group SA
 Cellnovo Group SA Medical SpecialtiesHealth Technology Manufactures medical device that manages diabetic control | Health Technology |
Curetis GmbH
 Curetis GmbH Medical SpecialtiesHealth Technology Develops miniaturized and integrated molecular diagnostic solutions | Health Technology |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Provides genomics technologies for clinical management of cancer | Health Technology |
Technologieholding VC GmbH | |
Forbion Capital Partners Germany GmbH
Forbion Capital Partners Germany GmbH Investment ManagersFinance Functions as an alternative investment manager | Finance |
Allecra Therapeutics GmbH
Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures pharmaceuticals to combat multi drug-resistant bacterial infections | Health Technology |
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology Develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation | Health Technology |
Rigontec GmbH
 Rigontec GmbH Pharmaceuticals: MajorHealth Technology Provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases | Health Technology |
Cellnovo Ltd.
Cellnovo Ltd. Medical SpecialtiesHealth Technology Manufactures diabetes management devices | Health Technology |
Curetis NV
 Curetis NV Medical/Nursing ServicesHealth Services Develops miniaturized and integrated molecular diagnostic solutions | Health Services |
CatalYm GmbH
CatalYm GmbH Pharmaceuticals: MajorHealth Technology Specializes in catalyzing immunotherapy | Health Technology |
Gotham Therapeutics Corp.
Gotham Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical medicines | Health Technology |
